MERGERS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Good news for any of you who slept through December 2017: You didn't miss much—at least as far as blockbuster strategic deals in the clinical laboratory space are concerned. M&AIn contrast to … [Read more...]

DISTRIBUTION AGREEMENTS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The pattern of high volume and relatively low impact continued with strategic alliances outnumbering acquisitions at rate of roughly 3:1. M&A Following the trio of mega-deal closings, … [Read more...]

AGREEMENTS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Deal volume was high during the month. But most of the deals were small and research-based. M&A It took over 18 months but the Abbott-Alere merger finally closed on Oct. 3. Alere got quite the … [Read more...]

MARKETING

Market Trends: Celebrity Power to Drive Testing Goes Beyond the ‘Angelina Jolie Effect’

The rates of genetic testing among women supposedly soared after Angelina Jolie revealed that she had undergone a double mastectomy to reduce her chances of developing breast cancer after learning … [Read more...]

ACQUISITIONS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry. M&A The preference of diagnostic companies to work with rather than digest each … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

It's been a relatively quiet month on the diagnostic front in terms of both deal volume and impact. Here's a rundown of the deals that did come down. M&A CRO acquisitions were the M&A … [Read more...]

DEAL TRENDS

Global Markets: Local Joint Ventures Represent New Path into China Market

While the strategy of targeting the China market is nothing new, the tactics have evolved. Recognizing the need for a strong local presence, western firms are increasingly teaming with operators on … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all transaction model sectors. Here are the highlights from the past … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Deal volume in May and June was noticeably higher, especially in terms of M&A activity. There was more global activity over the current than at any other point in 2017, particularly in Asia. Here … [Read more...]

NEWS AT A GLANCE

Another Decision in the HDL Case Highlights Kickback Risks of Patient Responsibility Waivers Involving Private Payers

The Health Diagnostics Laboratory, Inc. (HDL) and Singulex saga continues. The latest chapter involves not the labs themselves but BlueWave Healthcare Consultants, their marketing firm. And it raises … [Read more...]


(-00000g2)